Kevin Haninger
Kevin Haninger is Senior Vice President of International Advocacy at the Pharmaceutical Research and Manufacturers of America (PhRMA), where he manages market access, intellectual property, trade and global health policy advocacy in key markets. Prior to joining PhRMA, Kevin was Senior Economist in the Office of the Secretary at the U.S. Department of Health and Human Services. Kevin received an undergraduate degree with distinction from Stanford University and a Ph.D. from Harvard University.
PhRMA provides comments and testimony to USITC investigation on COVID-19 medicines and the TRIPS Agreement
Setting the record straight on international reference pricing
New analysis shows that more medicines worldwide are available to U.S. patients
In the OECD other health care services will be ten times prescription medicine spending growth over next decade
Foreign government price setting by any name harms innovation and access to medicines
Kevin Haninger